BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Treatment
47 results:

  • 1. Significance of Social Determinants of Health in tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology.
    Choudhry HS; Patel AM; Nguyen HN; Kaleem MA; Handa JT
    Am J Ophthalmol; 2024 Apr; 260():21-29. PubMed ID: 37956780
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
    Cui C; Chen Y; Luo Z; Zou Z; Jiang Y; Pan H; Fan Q; Zhao J; Xu Q; Jiang R; Wang X; Ma T; Guo Z; Si L; Chi Z; Sheng X; Dou Y; Tan Q; Wu D; Guo J
    BMC Cancer; 2023 Feb; 23(1):121. PubMed ID: 36747118
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. treatment and outcome trends and predictors of overall survival of rectal melanoma: Analysis of the National Cancer Database.
    Emile SH; Horesh N; Freund MR; Garoufalia Z; Gefen R; Silva-Alvarenga E; Wexner SD
    Eur J Surg Oncol; 2023 Jul; 49(7):1275-1282. PubMed ID: 36732208
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exploration of the prognostic value of the resection of adult brainstem high-grade glioma based on competing risk model, propensity score matching, and conditional survival rate.
    Zhang D; Li H; Jia W
    Neurol Sci; 2023 May; 44(5):1755-1764. PubMed ID: 36604383
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Endocrinopathy After treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy.
    Merchant TE; Wu S; Onar-Thomas A; Delaney A; Gajjar A
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):560-568. PubMed ID: 36563909
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy.
    Falade AS; Reynolds KL; Zubiri L; Deshpande V; Fintelmann FJ; Dougan M; Mooradian MJ
    Front Immunol; 2022; 13():871452. PubMed ID: 35493494
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma.
    Mulder EEAP; Damman J; Verver D; van der Veldt AAM; Tas S; Khemai-Mehraban T; Heezen KC; Wouters RA; Verhoef C; Verjans GMGM; Langerak AW; Grünhagen DJ; Mooyaart AL
    Melanoma Res; 2022 Aug; 32(4):249-259. PubMed ID: 35446267
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DAT negative warm autoimmune haemolytic anaemia secondary to a mature cystic teratoma refractory to immunosuppressive therapy.
    Denny N; Gordon E; Atoyebi O
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35232728
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A B-cell or a key player? The different roles of B-cells and antibodies in melanoma.
    Rodgers CB; Mustard CJ; McLean RT; Hutchison S; Pritchard AL
    Pigment Cell Melanoma Res; 2022 May; 35(3):303-319. PubMed ID: 35218154
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
    Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
    Şahin S; Ertekin E; Şahin T; Özsunar Y
    MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Anti-GD2 iga kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma.
    Evers M; Stip M; Keller K; Willemen H; Nederend M; Jansen M; Chan C; Budding K; Nierkens S; Valerius T; Meyer-Wentrup F; Eijkelkamp N; Leusen J
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34716207
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Amelanotic metastatic gastric malignant melanoma: a case report.
    Zhu M; Zhang DY; Zhang GJ; Wang ZB; Lid MY
    Anticancer Drugs; 2022 Jan; 33(1):e808-e812. PubMed ID: 34459456
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme.
    Guven DC; Aksun MS; Cakir IY; Kilickap S; Kertmen N
    Future Oncol; 2021 Nov; 17(32):4405-4413. PubMed ID: 34409854
    [No Abstract]    [Full Text] [Related]  

  • 15. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
    Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
    Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report.
    Kyriazis P; Tiwary A; Freeman J; Landry D; Braden G
    J Med Case Rep; 2021 Apr; 15(1):186. PubMed ID: 33810799
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Interim [
    Sachpekidis C; Kopp-Schneider A; Pan L; Papamichail D; Haberkorn U; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1932-1943. PubMed ID: 33336264
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
    Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
    J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
    Huang L; Chen H; Xu Y; Chen J; Liu Z; Xu Q
    Cancer Med; 2020 Nov; 9(22):8444-8456. PubMed ID: 32931642
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of T-cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic cell Vaccine Plus BCG and GM-CSF.
    Podaza E; Carri I; Aris M; von Euw E; Bravo AI; Blanco P; Ortiz Wilczyñski JM; Koile D; Yankilevich P; Nielsen M; Mordoh J; Barrio MM
    Front Immunol; 2020; 11():1147. PubMed ID: 32582212
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.